|
CDCA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88160000025306E-07 |
| Normal-vs-Stage2 |
2.867500E-02 |
| Normal-vs-Stage3 |
2.08800000000009E-05 |
| Normal-vs-Stage4 |
4.756600E-03 |
| Stage1-vs-Stage2 |
4.359200E-01 |
| Stage1-vs-Stage3 |
1.082340E-03 |
| Stage1-vs-Stage4 |
3.136500E-02 |
| Stage2-vs-Stage3 |
4.023900E-02 |
| Stage2-vs-Stage4 |
1.107780E-01 |
| Stage3-vs-Stage4 |
8.307800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24822374658606E-12 |
| Normal-vs-AfricanAmerican |
1.67424999999444E-05 |
| Normal-vs-Asian |
1.952100E-02 |
| Caucasian-vs-AfricanAmerican |
5.789200E-01 |
| Caucasian-vs-Asian |
5.314400E-01 |
| AfricanAmerican-vs-Asian |
3.220200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92550420052839E-11 |
| Normal-vs-Female |
2.36499999584083E-08 |
| Male-vs-Female |
5.381600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.59038999999472E-05 |
| Normal-vs-Extreme_Weight |
4.05710000039861E-07 |
| Normal-vs-Obese |
3.88429999997886E-06 |
| Normal-vs-Extreme_Obese |
1.184220E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.875700E-02 |
| Normal_Weight-vs-Obese |
6.503000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.834500E-04 |
| Extreme_Weight-vs-Obese |
2.172100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.096500E-03 |
| Obese-vs-Extreme_Obese |
2.605700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.216900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.17319520554338E-11 |
| Normal-vs-Age(61-80Yrs) |
4.2399999999887E-07 |
| Normal-vs-Age(81-100Yrs) |
1.391890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.852300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.315900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.135650E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.389000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.761700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.518400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.15570000014387E-07 |
| Normal-VS-Type2 PRCC |
2.98890001637631E-09 |
| Normal-VS-KIRP CIMP |
8.597900E-04 |
| Normal-VS-Unclassified PRCC |
3.59560000000592E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.457880E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.902640E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.570000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.643600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.234200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.241400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.58800000000081E-05 |
| Normal-vs-N1 |
5.89309999999843E-05 |
| Normal-vs-N2 |
1.035550E-01 |
| N0-vs-N1 |
1.958510E-03 |
| N0-vs-N2 |
6.070300E-02 |
| N1-vs-N2 |
5.843600E-01 |
|
|
